anal cancer
Addition of Retifanlimab to Chemotherapy Called New Standard for Anal Cancer
As part of first-line therapy for inoperable locally recurrent or metastatic squamous cell carcinoma of the anal ...
NOVEMBER 4, 2024
Anal Cancer Risk Differs by Region for People With HIV
A recent study that followed a cohort of more than 110,000 people found significant disparities in the risk for ...
AUGUST 30, 2024
ANCHOR in Practice: The Slow Path to Reducing the Incidence of Anal Cancer
Released last year, the ANCHOR study focused on preventing anal cancer through proactive treatment of precancerous ...
JUNE 23, 2023
Anal Cancer Risk Factors and Prevention: What Clinicians Should Know
Anal cancer is rare. Although the lifetime risk for anal cancer is about one in 500 in the general population, this ...
SEPTEMBER 28, 2022
Anal Cancer Rates in U.S. Rose From 2001 to 2016
The incidence of anal cancer in the United States has increased since 2001 among people ages 50 years and older, ...
JUNE 18, 2021
Investigational Immunotherapy Looks Positive for HPV-Related Epithelial Cancers
In this phase 1 study, eight patients with metastatic HPV-16 cancers received a single infusion of KITE-439. In six ...
JULY 13, 2018
